TABLE 4.
Drug susceptibility testing and drug resistance patterns of common Gram-positive organisms detected among adult samples with positive urine culture for bacterial isolate in Kathmandu, Nepal, May–October 2019
| Drugs | Enterococcus (n = 184) | Staphylococcus aureus (n = 65) | ||||
|---|---|---|---|---|---|---|
|
|
|
|||||
| Test N | Resistant | Test N | Resistant | |||
|
|
|
|||||
| n | (%)* | n | (%)* | |||
| Amikacin | 6 | 5 | (83.3) | 9 | 1 | (11.1) |
| Amoxicillin clavulanate | 162 | 69 | (42.6) | 1 | 0 | (0.0) |
| Amoxicillin/ampicillin | 182 | 81 | (44.5) | 24 | 19 | (79.2) |
| Ampicillin-sulbactam | 1 | 0 | (0.0) | 1 | 0 | (0.0) |
| Cefoperazone-sulbactam | — | — | — | 1 | 0 | (0.0) |
| Cefepime | — | — | — | 1 | 0 | (0.0) |
| Cefixime/ceftriaxone | — | — | — | 3 | 1 | (33.3) |
| Ceftazidime | — | — | — | 1 | 0 | (0.0) |
| Chloramphenicol | 144 | 12 | (8.3) | 11 | 1 | (9.1) |
| Ciprofloxacin | 141 | 102 | (72.3) | 55 | 18 | (32.7) |
| Cotrimoxazole | — | — | — | 54 | 15 | (27.8) |
| Doxycycline | 143 | 120 | (83.9) | 4 | 0 | (0.0) |
| Gentamycin | 160 | 90 | (56.3) | 56 | 6 | (10.7) |
| Imipenem | 2 | 1 | (50.0) | 1 | 0 | (0.0) |
| Levofloxacin | 164 | 110 | (67.1) | 9 | 2 | (22.2) |
| Meropenem | 20 | 15 | (75.0) | 1 | 0 | (0.0) |
| Nitrofurantoin | 166 | 44 | (26.5) | 61 | 2 | (3.3) |
| Cephalexin | — | — | — | 57 | 8 | (14.0) |
| Norfloxacin | 64 | 51 | (79.7) | — | — | — |
| Piperacillin-tazobactam | 159 | 75 | (47.2) | — | — | — |
| Vancomycin | 174 | 4 | (2.3) | — | — | — |
| Teicoplanin | 170 | 2 | (1.2) | — | — | — |
*Column percentage.